Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10037)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
PLA2G6
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Unspecific Target [Unspecific Target]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Responsed Disease | Melanoma | ICD-11: 2C30 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Apoptosis | hsa04210 | ||||
Cell Process | Cell ferroptosis | ||||
Cell apoptosis | |||||
Cell proliferation | |||||
Cell migration | |||||
Cell invasion | |||||
Cell metastasis | |||||
In Vitro Model |
SK-MEL-28 cells | Cutaneous melanoma | Homo sapiens | CVCL_0526 | |
M14 cells | Melanoma | Homo sapiens | CVCL_1395 | ||
A-375 cells | Amelanotic melanoma | Homo sapiens | CVCL_0132 | ||
A875 cells | Melanoma | Homo sapiens | CVCL_4733 | ||
In Vivo Model |
A total of 10 female BALB/c nude mice (4-6 weeks old) were supplied by Shanghai SLAC Laboratory Animal Co., Ltd (Shanghai, China). The nude mice were randomly divided into different treatment groups with five mice each, and maintained in a pathogen-free animal facility, followed by subcutaneously injection with 1 x 107 cells/mL M14 cells in 100 uL PBS on the right side to establish a subcutaneous xenograft model.
Click to Show/Hide
|
||||
Response regulation | The GO and KEGG analysis suggested that the underlying mechanism of PLA2G6 in cutaneous malignant melanoma (CMM) might be associated with the ferroptosis pathway, and ferroptosis-related proteins were validated to be differentially expressed in PLA2G6 knockdown SK-MEL-28 and M14 cells. Together, PLA2G6 knockdown significantly inhibited cell proliferation, metastasis, and promoted apoptosis in melanoma. | ||||
Melanoma [ICD-11: 2C30]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | 85/88 kDa calcium-independent phospholipase A2 (PLA2G6) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Apoptosis | hsa04210 | ||||
Cell Process | Cell ferroptosis | ||||
Cell apoptosis | |||||
Cell proliferation | |||||
Cell migration | |||||
Cell invasion | |||||
Cell metastasis | |||||
In Vitro Model |
SK-MEL-28 cells | Cutaneous melanoma | Homo sapiens | CVCL_0526 | |
M14 cells | Melanoma | Homo sapiens | CVCL_1395 | ||
A-375 cells | Amelanotic melanoma | Homo sapiens | CVCL_0132 | ||
A875 cells | Melanoma | Homo sapiens | CVCL_4733 | ||
In Vivo Model |
A total of 10 female BALB/c nude mice (4-6 weeks old) were supplied by Shanghai SLAC Laboratory Animal Co., Ltd (Shanghai, China). The nude mice were randomly divided into different treatment groups with five mice each, and maintained in a pathogen-free animal facility, followed by subcutaneously injection with 1 x 107 cells/mL M14 cells in 100 uL PBS on the right side to establish a subcutaneous xenograft model.
Click to Show/Hide
|
||||
Response regulation | The GO and KEGG analysis suggested that the underlying mechanism of PLA2G6 in cutaneous malignant melanoma (CMM) might be associated with the ferroptosis pathway, and ferroptosis-related proteins were validated to be differentially expressed in PLA2G6 knockdown SK-MEL-28 and M14 cells. Together, PLA2G6 knockdown significantly inhibited cell proliferation, metastasis, and promoted apoptosis in melanoma. | ||||